About: http://webisa.webdatacommons.org/401554353

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The investigational drug tofacitinib is an oral Janus kinase (JAK) inhibitor in development as a targeted immunomodulator for the treatment of rheumatoid arthritis, psoriasis, and other indications.
http://www.w3.org/ns/prov#wasQuotedFrom	genengnews.com